ITI is a program of The Task Force for Global Health.
Though there was a lot of historical evidence of endemic trachoma in Sudan, it was not until 2006 that population-based prevalence surveys were conducted to determine whether public health interventions were warranted to eliminate the disease. Mapping began in 2006 and to date 132 of the 147 districts have been mapped. There remain a few districts scattered among the five regions that comprise Darfur where insecurity has prevented the collection of data.
Partners in full SAFE implementation include The Carter Center (TCC), Sightsavers (SSI), and The End Fund. Sudan’s target year of elimination is 2020.
Sudan shares a border with seven countries and the Red Sea: CAR, Chad, Egypt, Eritrea, Ethiopia, Libya and South Sudan, of which, six are known to be endemic for trachoma: CAR, Chad, Egypt, Eritrea, Ethiopia and South Sudan.
In 2016, Sudan requested Zithromax® for 16 districts and was able to conduct distribution in 13 districts. In a huge accomplishment, the national program were able to launch MDAs in the hitherto inaccessible areas of Darfur.
Zithromax® Shipments by Year